Abstract
Several earlier studies have shown that some human pituitary GH-secreting somatotrophinomas are able to synthesise and release hypothalamic GHRH and it has been proposed that a positive autocrine feedback loop involving this tumor-derived GHRH may participate in tumorigenesis. We have used in-vitro cell culture and exploited an antagonist to GHRH, (Ac-Tyr1,D-Arg2-GHRH (1–29)-amide (GHRH-A), to further investigate whether an autocrine loop involving somatotrophinoma-derived GHRH may exist. In situ hybridization demonstrated presence of GHRH transcripts in 5 of 9 human somatotrophinomas. In culture, GHRH-A failed to inhibit basal release of GH or production of cAMP irrespective of presence or absence of GHRH transcripts. However, GHRH-A was able to completely or partially abolish the stimulatory effects of exogenously added GHRH peptide. Additionally, the average stimulatory effect of exogenous GHRH on in vitro GH secretion by somatotrophinomas possessing GHRH mRNA was identical to that shown by tumors not expressing the GHRH gene. Whilst confirming that many human pituitary somatotrophinomas are able to express the GHRH gene, the failure of GHRH-A to inhibit basal GH secretion argues against the concept of the existence of an autocrine stimulatory loop involving secreted GHRH peptide.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Harris GW. Neural Control of the Pituitary Gland. London: Edward Arnold Publishers, 1955.
Brazeau P, Vale W, Burgus R, Ling N, Butcher M, Rivier J, Guillemin R. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 1973;179:77–79.
Rivier J, Spiess J, Thorner M, Vale W. Characterisation of a growth hormone releasing factor from a human pancreatic islet tumour. Nature 1982;300:276–278.
Guilleman R, Brazeau P, Bohlen PE, Esch F, Ling N, Wehrenberg W. Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly. Science 1982;218:585–587.
Joubert (Bression) D, Benlot C, Lagoguey A, Garnier P, Brabdi AM, Gautron JP, Legrand JC, Peillon F. Normal and growth hormone (GH)-secreting adenomatous human pituitaries release somatostatin and GH-releasing hormone. J Clin Endocrinol Metab 1989;68:572–577.
Levy A, Lightman SL. Growth hormone-releasing hormone transcripts in human pituitary adenomas. J Clin Endocrinol Metab 1992;74:1474–1476.
Levy A, Lightman SL. Relationship between somatostatin and growth hormone messenger ribonucleic acid in human pituitary adenomas: An in-situ hybridization histochemistry study. Clin Endocrinol 1990;32:661–668.
Wakabayashi I, Inokuchi K, Hasegawa O, Sugihara H, Minami S. Expression of growth hormone (GH)-releasing factor gene in GH-producing pituitary adenoma. J Clin Endocrinol Metab 1992;74:357–361.
Le Dafniet M, Blumberg-Tick J, Gozlan H, Barret A, Joubert (Bression) D, Peillon F. Altered balance between thyrotropin-releasing hormone and dopamine in prolactinomas and other pituitary tumors compared to normal pituitaries. J Clin Endocrinol Metab 1989;69:267–271.
Joubert D, Le Dafniet M, Pagesy P, Li Y, Benlot C, Peillon F. Neuropeptides as autocrine or paracrine factors of anterior pituitary secretion. In: Faglia G, Beck-Peccoz P, Ambrosi B, Travaglini P, Spada A, eds. Pituitary Adenomas: New Trends in Basic and Clinical Research. Elsevier Science Publishers, 1991:55–64.
Peillon F, Joubert D, Pagesy P, Li JY, Brandi AM, Le Dafniet M. Receptor and neuropeptide studies in nonsecreting pituitary adenomas. In: Faglia G, Beck-Peccoz P, Ambrosi B, Travaglini P, Spada A, eds. Pituitary Adenomas: New Trends in Basic and Clinical Research. Elsevier Science Publishers, 1991:55–64.
Robberecht P, Coy DH, Waelbroeck M, Heiman ML, de Neef P, Camus JC, Christophe J. Structural requirements for the activation of rat anterior pituitary adenylate cyclase by growth hormone-releasing factor (GRF): Discovery of (NAc Tyr1, D-Arg2)-GHRH(1-29)-NH2 as a GRF antagonist on membranes. Endocrinology 1985;117:1759–1764.
Adams EF, Lei T, Buchfelder M, Petersen B, Fahlbusch R. Biochemical characteristics of human pituitary somatotropinomas with and without gsp mutations: In vitro cell culture studies. J Clin Endocrinol Metab 1995;80:2077–2081.
Adams EF, Lei T, Buchfelder M, Bowers CY, Fahlbusch R. Protein kinase C-dependent growth hormone releasing peptides stimulate cyclic adenosine 3',5'-monophosphate production by human pituitary somatotropinomas expressing gsp oncogenes: Evidence for cross-talk between transduction pathways. Mol Endocrinol 1996;10:432–438.
Young WSIII, Bonner TI, Brann MR. Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain. Proc Natl Acad Sci USA 1986;83:9827–9831.
Landis CA, Masters SB, Spada A, Pace AM, Bourne HR, Vallar L. GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenyl cyclase in human pituitary tumours. Nature 1989;340:692–696.
Adams EF, Brockmeier S, Friedman E, Roth M, Buchfelder M, Fahlbusch R. Clinical and biochemical characteristics of acromegalic patients harboring gsp-positive and gsp-negative pituitary tumors. Neurosurgery 1993;33:198–203.
Ueta Y, Levy A, Powell M, Lightman SL, Yoshimasa K, Yokata A, Yamashita H. Neuronal nitric oxide synthase gene expression in human pituitary tumours: A possible association with somatotroph adenomas and growth hormone-releasing hormone gene expression. Clin Endocrinol 1997 (in press).
Levy A, Lightman SL. Local production of hypothalamic trophic peptides in human pituitary tumours. Clin Chem Enz Comm 1992;5:265–273.
Levy A, Powell M, Lightman SL. Colocalization of corticotrophin-releasing hormone and oxytocin transcripts in human pituitary adenomas. Endo J 1993;1:117–122.
Bennett PA, Levy A, Sophokleous S, Robinson ICAF, Lightman SL. Hypothalamic growth hormone receptor gene expression in the rat: Effects of altered growth hormone status. J Endocrinol 1995;147:225–234.
Adams EF, Buchfelder M, Lei T, Petersen B, Fahlbusch R. Molecular biology of growth-hormone-secreting human pituitary tumours: Biochemical consequences and potential clinical significance. In: Fahlbusch R, Bock WJ, Brock M, Buchfelder M, Klinger M, eds. Modern Neurosurgery of Meningiomas and Pituitary Adenomas. Springer Publishers, 1996:7–10.
Billestrup N, Swanson LW, Vale W. Growth hormone-releasing factor stimulates proliferation of somatotrophs in vitro. Proc Natl Acad Sci USA 1986;83:6854–6857.
Mayo KE, Hammer RE, Swanson LW, Brinster RL, Rosenfeld MG, Evans RM. Dramatic pituitary hyperplasia in transgenic mice expressing a growth hormone-releasing factor gene. Mol Endocrinol 1985;2:606–612.
Burton FH, Hasel KW, Bloom FE, Sutcliffe JG. Pituitary hyperplasia and gigantism in mice caused by a cholera toxin transgene. Nature 1991;350:74–77.
Cheng K, Chan WWS, Barreto A, Convey EM, Smith RG. The synergistic effects of His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 on growth hormone (GH)-releasing factor-stimulated 3',5'-monphosphate accumulation in rat primary pituitary cell culture. Endocrinology 1989;124:2791–2798.
Wu D, Chen C, Katoh K, Zhang J, Clarke IJ. The effect of GH-releasing peptide-2 (GHRP-2 or KP 102) on GH secretion from primary cultured ovine pituitary cells can be abolished by a specific GH-releasing factor (GRF) receptor antagonist. J Endocrinol 1994;140:R9–R13.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Adams, E.F., Law, H., Buchfelder, M. et al. Presence of GHRH mRNA in Human Pituitary Somatotrophinomas and Its Relationship to in vitro Effect of a GHRH-antagonist on GH Secretion and cAMP Production. Pituitary 1, 7–12 (1998). https://doi.org/10.1023/A:1009917306289
Issue Date:
DOI: https://doi.org/10.1023/A:1009917306289